morning traders 1 / 11, page-7

MXC looking good...

•Heads of Agreement (“HOA”) signed with specialist Australian pharmaceutical distributor, HL Pharma Pty Ltd to bring MGC Pharmaceuticals’ affordable epilepsy product, CannEpilTM to the Australian market for treating epilepsy patients

• Definitive Agreement to be finalised and executed within 14 days of signing the HOA

• Sets in place the timeline for multiple milestones, including delivery of the first MGC Pharmaceuticals’ medical cannabis products to Australian epilepsy patients

• Signifies the commencement of Australian sales pipeline and revenue stream

• Leverages MGC Pharmaceuticals’ established relationship with Epilepsy Action Australia to rapidly build an Australian patient market through multiple prescribing Australian doctors, at an affordable retail price for patients

• Deal set to generate significant medical cannabis revenues for MXC, expected to be approximately $1m in 2018 from less than 100 patients already registered

• Potential market of +70,000 Australians suffering from drug-resistant epilepsy

• Delivery of the first products to patients set to commence during Q1 2018